In 2011, at the age of three, Malia was first diagnosed with stage 4, high-risk neuroblastoma. Malia endured a difficult two-year treatment regimen and had been doing well until April of 2021 when she relapsed and promptly resumed treatment. Since her relapse Malia has experienced many side effects, requiring several unplanned hospital admissions and frequent clinic visits, and is facing an uncertain prognosis. Malia and her 5-year-old brother live with their parents in Southeastern, Massachusetts. The family had only recently “gotten back on their financial feet” after Malia’s initial diagnosis when she relapsed. Both of Malia’s parents have missed work and lost a substantial amount of income due to her treatment and the ongoing pandemic. They are now struggling to keep up with essential household expenses. A grant from the One Mission Fund at Dana-Farber Cancer Institute covered a mortgage payment for the family, helping relieve some of their financial burdens.